Bayer invests USD 2.2 billion in new Ohio pharma manufacturing site

• Bayer AG plans to invest USD 2.2 billion to build a new pharmaceutical manufacturing site in New Albany, Ohio.
• Project targets about 600 permanent jobs, with about 1,500 construction jobs during the buildout.
• Campus will combine drug substance and drug product manufacturing, with an initial focus on oncology, cardiovascular, renal care.
• First module for drug substance manufacturing is slated to start operations in 2031.
• Second module for drug product manufacturing is planned to follow in 2034.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayer AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20261002202241) on October 02, 2026, and is solely responsible for the information contained therein.